Literature DB >> 21430769

Schizophrenia: Zooming in on a gene.

Hugh D Piggins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21430769     DOI： 10.1038/471455a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

Review 1.  VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.

Authors:  Terry W Moody; Tetsuhide Ito; Nuramy Osefo; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-02       Impact factor: 3.243

2.  Gastrin-releasing peptide promotes suprachiasmatic nuclei cellular rhythmicity in the absence of vasoactive intestinal polypeptide-VPAC2 receptor signaling.

Authors:  Timothy M Brown; Alun T Hughes; Hugh D Piggins
Journal:  J Neurosci       Date:  2005-11-30       Impact factor: 6.167

3.  Microdeletions of 3q29 confer high risk for schizophrenia.

Authors:  Jennifer Gladys Mulle; Anne F Dodd; John A McGrath; Paula S Wolyniec; Adele A Mitchell; Amol C Shetty; Nara L Sobreira; David Valle; M Katharine Rudd; Glen Satten; David J Cutler; Ann E Pulver; Stephen T Warren
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

4.  Aberrant gating of photic input to the suprachiasmatic circadian pacemaker of mice lacking the VPAC2 receptor.

Authors:  Alun T Hughes; Briana Fahey; David J Cutler; Andrew N Coogan; Hugh D Piggins
Journal:  J Neurosci       Date:  2004-04-07       Impact factor: 6.167

5.  Circadian control of mouse heart rate and blood pressure by the suprachiasmatic nuclei: behavioral effects are more significant than direct outputs.

Authors:  W John Sheward; Erik Naylor; Seymour Knowles-Barley; J Douglas Armstrong; Gillian A Brooker; Jonathan R Seckl; Fred W Turek; Megan C Holmes; Phyllis C Zee; Anthony J Harmar
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 6.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

Review 7.  The role of DNA copy number variation in schizophrenia.

Authors:  Gloria W C Tam; Richard Redon; Nigel P Carter; Seth G N Grant
Journal:  Biol Psychiatry       Date:  2009-09-12       Impact factor: 13.382

Review 8.  Capturing adenylyl cyclases as potential drug targets.

Authors:  Sandra Pierre; Thomas Eschenhagen; Gerd Geisslinger; Klaus Scholich
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

9.  Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications.

Authors:  Douglas F Levinson; Jubao Duan; Sang Oh; Kai Wang; Alan R Sanders; Jianxin Shi; Nancy Zhang; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Kenneth S Kendler; Robert Freedman; Frank Dudbridge; Itsik Pe'er; Hakon Hakonarson; Sarah E Bergen; Ayman H Fanous; Peter A Holmans; Pablo V Gejman
Journal:  Am J Psychiatry       Date:  2011-02-01       Impact factor: 18.112

10.  Select cognitive deficits in vasoactive intestinal peptide deficient mice.

Authors:  Dipesh Chaudhury; Dawn H Loh; Joanna M Dragich; Arkady Hagopian; Christopher S Colwell
Journal:  BMC Neurosci       Date:  2008-07-10       Impact factor: 3.288
View more
  3 in total

Review 1.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings.

Authors:  Alex V Kotlar; Kristina B Mercer; Michael E Zwick; Jennifer G Mulle
Journal:  Eur J Med Genet       Date:  2015-10-19       Impact factor: 2.708

3.  Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Appl Clin Genet       Date:  2012-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.